Literature DB >> 7649576

Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressure-independent mechanism.

V L Brooks1.   

Abstract

The purpose of this study was to test the hypothesis that chronic infusion of angiotensin II (Ang II) in rabbits resets the cardiac baroreflex to a higher arterial pressure level by a pressure-independent mechanism. This hypothesis was tested by determining whether the resetting would be reversed soon after the Ang II infusion was stopped even if the hypertension was maintained by infusion of another vasoconstrictor. Relationships between arterial pressure and heart rate were determined by infusion of increasing doses of nitroprusside to decrease pressure and increase heart rate, followed by increasing doses of phenylephrine to increase pressure and decrease heart rate. After 9 to 10 days of Ang II infusion (20 ng.kg-1.min-1) arterial pressure was increased from 62 +/- 2 to 94 +/- 3 mm Hg (P < .001), and heart rate was unchanged from control values of 126 +/- 7 beats per minute. The baroreflex relationship between arterial pressure and heart rate was shifted to a higher pressure level after 3 to 4 and 9 to 10 days of Ang II infusion. On these same days the Ang II infusion was replaced with phenylephrine (5.0 +/- 0.4 micrograms.kg-1.min-1), and 30 minutes later arterial pressure decreased slightly (P < .05); however, despite the relative hypotension, heart rate was decreased (P < .005) from 126 +/- 5 to 98 +/- 7 beats per minute (days 3 to 4) and from 132 +/- 4 to 103 +/- 7 beats per minute (days 9 to 10). Moreover, the cardiac baroreflex relationships were shifted back to a lower pressure level (P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649576     DOI: 10.1161/01.hyp.26.3.420

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Altered systemic hemodynamic and baroreflex response to angiotensin II in postural tachycardia syndrome.

Authors:  Hossam I Mustafa; Satish R Raj; André Diedrich; Bonnie K Black; Sachin Y Paranjape; William D Dupont; Gordon H Williams; Italo Biaggioni; David Robertson
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-01-13

Review 2.  Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

Authors:  I H Zucker; J L Liu
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

3.  Angiotensin-(1-7) and baroreflex function in nucleus tractus solitarii of (mRen2)27 transgenic rats.

Authors:  Debra I Diz; Maria Antonia Garcia-Espinosa; Patricia E Gallagher; Detlev Ganten; Carlos M Ferrario; David B Averill
Journal:  J Cardiovasc Pharmacol       Date:  2008-06       Impact factor: 3.105

4.  High levels of circulating angiotensin II shift the open-loop baroreflex control of splanchnic sympathetic nerve activity, heart rate and arterial pressure in anesthetized rats.

Authors:  Toru Kawada; Atsunori Kamiya; Meihua Li; Shuji Shimizu; Kazunori Uemura; Hiromi Yamamoto; Masaru Sugimachi
Journal:  J Physiol Sci       Date:  2009-08-18       Impact factor: 2.781

5.  Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.

Authors:  D C Merrill; M W Thompson; C L Carney; B P Granwehr; G Schlager; J E Robillard; C D Sigmund
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control.

Authors:  Jyoti Patel; Surawee Chuaiphichai; Gillian Douglas; Caroline M Gorvin; Keith M Channon
Journal:  Vascul Pharmacol       Date:  2018-04-11       Impact factor: 5.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.